Showing results (151-160 of 525) with videos related to
Sort By:
Pageof 53
Advances in Radiation Oncology|April 7, 2022
Phantosmia Among Pediatric, Adolescent, and Young Adult Patients Receiving Proton Beam TherapyShoshana J Rosenzweig, Stanislav Lazarev, Shaakir Hasan, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 20, 2018
A prospective study of the feasibility of FDG-PET/CT imaging to quantify radiation-induced lung inflammation in locally advanced non-small cell lung cancer patients receiving proton or photon radiotherapyPegah Jahangiri, Kamyar Pournazari, Drew A Torigian, et al.Medical Care|April 1, 1992
HMO marketing and selection bias: are TEFRA HMOs skimming?R Lichtenstein, J W Thomas, B Watkins, et al.Annals of Palliative Medicine|January 13, 2023
Society for Palliative Radiation Oncology: Report from the Ninth Annual Meeting (2022)Jordan Hill, Candice Johnstone, Emily Martin, et al.Annals of Surgical Oncology|May 4, 2018
Malignant Peritoneal Mesothelioma: National Practice Patterns, Outcomes, and Predictors of SurvivalVivek Verma, Richard L Sleightholm, Chad G Rusthoven, et al.JCO Precision Oncology|March 18, 2026
Diffuse Pleural Mesothelioma in Young (Age ≤50 Years) and Very Young (Age ≤35 Years) Patients: Clinical Characteristics, Genomics, and SurvivalHely Ollila, Amina Tidjani, Jennifer L Sauter, et al.Seminars in Thoracic and Cardiovascular Surgery|June 22, 2019
Management of Clinically Lymph Node-Positive Malignant Pleural MesotheliomaVivek Verma, Rodney E Wegner, Sebastian Adeberg, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 24, 2014
Investigating an outbreak of Clostridium perfringens gastroenteritis in a school using smartphone technology, London, March 2013B Simone, C Atchison, B Ruiz, et al.Cancers|June 24, 2022
Proton Therapy in the Management of Luminal Gastrointestinal Cancers: Esophagus, Stomach, and AnorectumJana M Kobeissi, Charles B Simone, Lara Hilal, et al.Journal for Immunotherapy of Cancer|November 25, 2018
A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitorsVivek Verma, Tanja Sprave, Waqar Haque, et al.Pageof 53